Chemotherapeutic Evaluation of 5-Episisomicin (Sch 22591), a New Semisynthetic Aminoglycoside
AUTOR(ES)
Waitz, J. Allan
RESUMO
5-episisomicin (Sch 22591) is a novel semisynthetic aminoglycoside with a spectrum and potency similar to gentamicin in its activity against susceptible bacterial strains, but with increased potency against Pseudomonas, Providencia, and Proteus rettgeri. It is also more active than tobramycin and amikacin against these last-mentioned species.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352182Documentos Relacionados
- Comparison of 5-Episisomicin (Sch 22591), Gentamicin, Sisomicin, and Tobramycin in Treatment of Experimental Pseudomonas Infections in Mice
- In Vitro Activity of 5-Episisomicin in Bacteria Resistant to Other Aminoglycoside Antibiotics
- In Vitro Evaluation of a Semisynthetic Derivative of Gentamicin B (SCH 21420)
- Activity of 5-Episisomicin Compared with That of Other Aminoglycosides
- In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent.
